mstrust.org.uk3d
Simvastatin not effective at slowing disability progression in secondary progressive MS
Initial results from a phase III clinical trial show that simvastatin does not slow down progression in secondary progressive ...
Texas Instruments5d
BQ25756: Odd behavior from STAT1 & STAT2 LEDs
I get a fault output on STAT1 & STAT2 when the voltage is under 12V, when I programmed it via hardware to have a minimum input of 9V. Here is a link to my design ...
BMJ2d
AB0494 Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, Shows Similar PK and PD Profiles in Japanese and Caucasian Healthy Volunteers
The PK of filgotinib and its active metabolite were evaluated, and the overall PD of the two moieties was assessed in whole blood using ex vivo IL-6 induced phosphorylation of STAT1 (pSTAT1) as ...
eLife2d
IFIT1 is rapidly evolving and exhibits disparate antiviral activities across 11 mammalian orders
This valuable report describes the changing antiviral activity of IFIT1 across mammals and in response to distinct viruses, likely as a result of past arms races. One of the main strengths of the ...
Medscape1d
The Concurrent Chemoradiation Paradigm-General Principles
Summary and Introduction Clinical Application—Disease Entities Theoretical Framework for Therapy−The 'Steel Paradigm' Conclusion References Theoretical Framework for Therapy−The 'Steel ...